alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,301–7,325 of 7,816 matching trials · page 293 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Multicenter Vitamin E Trial in Aging Persons With Down Syndrome
NCT01594346
Alpha-Tocopherol; Sugar Pill 		PHASE3
other		 COMPLETED 349 New York State Institute for Basic Research
OTHER_GOV		 2012-05-09
Vitamin E in Aging Persons With Down Syndrome
NCT00056329
Vitamin E; multivitamin; Placebo
Runs in: Australia; Canada; United Kingdom; United States · 22 sites 		PHASE3
other		 UNKNOWN 350 New York State Institute for Basic Research
OTHER_GOV		 2012-05-04
Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
NCT00165763
donepezil hydrochloride (Aricept)
Runs in: Philippines · 2 sites 		PHASE4
symptomatic-cholinergic		 COMPLETED 36 Eisai Inc.
INDUSTRY		 2012-05-04
A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease
NCT01482845
ABT-126; Placebo
Runs in: United States · 3 sites 		PHASE1
other		 COMPLETED 20 Abbott
INDUSTRY		 2012-05-02
Evaluation of Alteration by Magnetic Resonance Imaging (MRI) in Dementia Among Elderly Subjects
NCT00951197
Neuroimaging
Runs in: France · 1 site 		NA
other		 COMPLETED 318 University Hospital, Bordeaux
OTHER		 2012-04-30
Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
NCT00767091
rivastigmine; placebo
Runs in: France · 1 site 		PHASE3
symptomatic-cholinergic		 COMPLETED 40 University Hospital, Lille
OTHER		 2012-04-24
The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease
NCT01297218
Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells
Runs in: South Korea · 1 site 		PHASE1
other		 COMPLETED 9 Medipost Co Ltd.
INDUSTRY		 2012-04-23
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease
NCT00766363
EVP-6124 (0.1 mg/day); EVP-6124 (0.3 mg/day); EVP-6124 (1.0 mg/day)...
Runs in: United States · 4 sites 		PHASE1
symptomatic-cholinergic		 COMPLETED 49 FORUM Pharmaceuticals Inc
INDUSTRY		 2012-04-20
Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease
NCT00561392
Rivastigmine 5 and 10 cm^2 patch
Runs in: Germany · 1 site 		PHASE4
symptomatic-cholinergic		 COMPLETED 208 Novartis
INDUSTRY		 2012-04-16
The Effect of Dexmedetomidine on Emergence Agitation in Children Undergoing a Surgery Under Desflurane Anesthesia
NCT01578161
Dexmedetomidine; 0.9% Normal Saline
Runs in: South Korea · 1 site 		PHASE4
other		 UNKNOWN 116 Seoul National University Hospital
OTHER		 2012-04-16
An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine
NCT00297414
No intervention
Runs in: Argentina; Australia; Austria; Belgium; Canada; Czechia; ... · 144 sites 		NA
symptomatic-cholinergic		 COMPLETED 1,083 Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY		 2012-04-12
The Mental Activity and eXercise Trial for Seniors
NCT00522899
Group 1; Group 2; Group 3; Group 4
Runs in: United States · 2 sites 		NA
other		 COMPLETED 126 University of California, San Francisco
OTHER		 2012-04-09
Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease
NCT01569516
Octohydroaminoacridine Succinate Tablets; Octohydroaminoacridine Su...
Runs in: China · 13 sites 		PHASE2
other		 UNKNOWN 288 Changchun Huayang High-tech Co., Ltd
INDUSTRY		 2012-04-09
Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers
NCT01348737
AZD3839; AZD3839 Placebo
Runs in: United Kingdom · 1 site 		PHASE1
other		 COMPLETED 72 AstraZeneca
INDUSTRY		 2012-04-06
Memory Disorders Registry
NCT00654563
Runs in: United States · 1 site 		NA
other		 COMPLETED 12 Cedars-Sinai Medical Center
OTHER		 2012-03-27
A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease
NCT00297362
Galantamine hydrobromide 		NA
symptomatic-cholinergic		 COMPLETED 344 Janssen Cilag Pharmaceutica S.A.C.I., Greece
INDUSTRY		 2012-03-26
Non Pharmacological Management of Behavioural Symptoms in Nursing Home
NCT00824967
Training and valuation of the treating personnel
Runs in: France · 1 site 		NA
other		 TERMINATED 306 Centre Hospitalier Universitaire de Nice
OTHER		 2012-03-26
Comparison of 3 Learning Methods to Improve Independent Activities of Daily Living (IADLs) in Alzheimer Disease
NCT01095718
Errorless Learning; Modeling; Trial and Error
Runs in: France · 1 site 		NA
other		 UNKNOWN 300 Department of Clinical Research and Innovation
OTHER		 2012-03-26
Truncated and Extended Forms of Amyloid Beta Peptides in Alzheimer's Disease: Genesis, Toxicity and Identification as Biological Markers
NCT01128725
Alzhamyd
Runs in: France · 1 site 		NA
other		 UNKNOWN 100 Centre Hospitalier Universitaire de Nice
OTHER		 2012-03-26
Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients
NCT01183806
Rivastigmine; Exercise training program
Runs in: Brazil · 2 sites 		PHASE3
symptomatic-cholinergic		 COMPLETED 40 Federal University of Bahia
OTHER		 2012-03-20
Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)
NCT01554033
Runs in: South Korea · 1 site 		NA
other		 UNKNOWN 200 Seoul National University Hospital
OTHER		 2012-03-19
AAB-001 in Patients With Mild to Moderate Alzheimer's Disease
NCT00112073
bapineuzumab; placebo
Runs in: United States · 26 sites 		PHASE2
anti-amyloid-antibody		 COMPLETED 234 JANSSEN Alzheimer Immunotherapy Research & Development, LLC
INDUSTRY		 2012-03-14
Reducing Aggression in Children and Adolescent on an Inpatient Unit
NCT01377948
ACT with RAGE-Control
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 20 Gonzalez-Heydrich, Joseph, M.D.
OTHER		 2012-03-12
Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders
NCT01316562
Runs in: France · 1 site 		NA
other		 UNKNOWN 500 University Hospital, Angers
OTHER_GOV		 2012-03-09
Self- Care TALK Study - Promoting Alzheimer's Disease (AD) Spousal Caregiver Health
NCT00646074
Self-Care Talk 		NA
other		 COMPLETED 46 University of Kansas
OTHER		 2012-03-07

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →